Priority Date: 02.04.12 (US 201261619258P)

DOSAGE AND ADMINISTRATION OF MONOSPECIFIC AND BISPECIFIC ANTI-IGF-1R AND ANTI-ERBB3 ANTIBODIES

  • Application ID: EP13717642
  • Status: APPLICATION WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1998
Headquarter in Sint-Martens-Latem and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) De Clercq & Partners cvba is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 02.04.2012 - Priority Date (US 201261619258P)
  • 10.10.2013 - Publication A1 (WO2013152034)
  • 11.02.2015 - Publication A1 (EP2833915)

IPC Classification